SCHEMBL4665580

SCHEMBL4665580

Cc1c(-c2ccccc2)nc2ccccc2c1C(=O)NCCc1ccccc1C#N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
ALDH1A1 P00352 3/20 0.55
HPGD P15428 1/20 0.55
TSHR P16473 2/20 0.53
PDE10A Q9Y233 2/20 0.53
PTGFR P43088 8/20 0.52
CYP3A4 P08684 3/20 0.52
TACR3 P29371 4/20 0.52
TACR2 P21452 2/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
TP53 P04637 2/20 0.52
MEN1 O00255 1/20 0.52
NFKB1 P19838 1/20 0.52
MAPK1 P28482 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
KMT2A Q03164 1/20 0.52
ATM Q13315 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4667328 0.88 LMNA (0.53) LMNAALDH1A1HPGDPDE10ACYP3A4
SCHEMBL4668727 0.88 LMNA (0.53) LMNAALDH1A1HPGDCYP3A4TACR3
SCHEMBL5045776 0.87 CYP2D6 (0.56) LMNAALDH1A1HPGDTSHRPDE10A
SCHEMBL4667842 0.87 TACR3 (0.56) LMNAALDH1A1HPGDCYP3A4TACR3
SCHEMBL4665602 0.87 LMNA (0.57) LMNAALDH1A1HPGDPDE10ACYP3A4
SCHEMBL5045996 0.86 LMNA (0.57) LMNAALDH1A1HPGDTSHRPDE10A
SCHEMBL5041963 0.86 TACR3 (0.55) LMNAALDH1A1HPGDTSHRPDE10A
SCHEMBL5042633 0.85 LMNA (0.56) LMNAALDH1A1HPGDCYP3A4TACR3
SCHEMBL5045721 0.85 LMNA (0.51) LMNAALDH1A1HPGDTSHRPDE10A
SCHEMBL5042219 0.84 LMNA (0.55) LMNAALDH1A1HPGDPTGFRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928834-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS AstraZeneca AB (SE) 2008-06-11 EP claimed
WO-2007035157-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2007-03-29 WO claimed
EP-1928834-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS AstraZeneca AB (SE) 2008-06-11 EP disclosed
WO-2007035157-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2007-03-29 WO disclosed